Literature DB >> 34011606

DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.

Kazuki Sato1,2,3, Yumi Yamashita-Kanemaru1,4, Fumie Abe1,4, Rikito Murata1,5, Yuho Nakamura-Shinya1,6, Kazumasa Kanemaru1,3, Masafumi Muratani7, André Veillette8, Motohito Goto9, Mamoru Ito9, Akira Shibuya1,2,3,4, Kazuko Shibuya10,3.   

Abstract

Regulatory T (Treg) cells that express forkhead box P3 (Foxp3) are pivotal for immune tolerance. Although inflammatory mediators cause Foxp3 instability and Treg cell dysfunction, their regulatory mechanisms remain incompletely understood. Here, we show that the transfer of Treg cells deficient in the activating immunoreceptor DNAM-1 ameliorated the development of graft-versus-host disease better than did wild-type Treg cells. We found that DNAM-1 competes with T cell immunoreceptor with Ig and ITIM domains (TIGIT) in binding to their common ligand CD155 and therefore regulates TIGIT signaling to down-regulate Treg cell function without DNAM-1-mediated intracellular signaling. DNAM-1 deficiency augments TIGIT signaling; this subsequently inhibits activation of the protein kinase B-mammalian target of rapamycin complex 1 pathway, resulting in the maintenance of Foxp3 expression and Treg cell function under inflammatory conditions. These findings demonstrate that DNAM-1 regulates Treg cell function via TIGIT signaling and thus, it is a potential molecular target for augmenting Treg function in inflammatory diseases.

Entities:  

Keywords:  DNAM-1; Foxp3; TIGIT; mTORC1; regulatory T (Treg) cells

Mesh:

Substances:

Year:  2021        PMID: 34011606      PMCID: PMC8166105          DOI: 10.1073/pnas.2021309118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.

Authors:  Xavier Valencia; Cheryl Yarboro; Gabor Illei; Peter E Lipsky
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

2.  The TIGIT/CD226 axis regulates human T cell function.

Authors:  Ester Lozano; Margarita Dominguez-Villar; Vijay Kuchroo; David A Hafler
Journal:  J Immunol       Date:  2012-03-16       Impact factor: 5.422

Review 3.  The regulation of immune tolerance by FOXP3.

Authors:  Ling Lu; Joseph Barbi; Fan Pan
Journal:  Nat Rev Immunol       Date:  2017-07-31       Impact factor: 53.106

4.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

Authors:  G R Hill; J M Crawford; K R Cooke; Y S Brinson; L Pan; J L Ferrara
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

5.  DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes.

Authors:  A Shibuya; D Campbell; C Hannum; H Yssel; K Franz-Bacon; T McClanahan; T Kitamura; J Nicholl; G R Sutherland; L L Lanier; J H Phillips
Journal:  Immunity       Date:  1996-06       Impact factor: 31.745

6.  Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

Authors:  Emmanuel Zorn; Haesook T Kim; Stephanie J Lee; Blair H Floyd; Despina Litsa; Sankari Arumugarajah; Roberto Bellucci; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Journal:  Blood       Date:  2005-06-21       Impact factor: 22.113

7.  Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).

Authors:  Satoko Tahara-Hanaoka; Kazuko Shibuya; Yuko Onoda; Hua Zhang; Satoshi Yamazaki; Akitomo Miyamoto; Shin-Ichiro Honda; Lewis L Lanier; Akira Shibuya
Journal:  Int Immunol       Date:  2004-04       Impact factor: 4.823

8.  T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR.

Authors:  Stephan Sauer; Ludovica Bruno; Arnulf Hertweck; David Finlay; Marion Leleu; Mikhail Spivakov; Zachary A Knight; Bradley S Cobb; Doreen Cantrell; Eric O'Connor; Kevan M Shokat; Amanda G Fisher; Matthias Merkenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-28       Impact factor: 11.205

9.  CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation.

Authors:  Kazuko Shibuya; Jun Shirakawa; Tomie Kameyama; Shin-Ichiro Honda; Satoko Tahara-Hanaoka; Akitomo Miyamoto; Masafumi Onodera; Takayuki Sumida; Hiromitsu Nakauchi; Hiroyuki Miyoshi; Akira Shibuya
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.

Authors:  Rong Zhang; Hanyu Zeng; Yun Zhang; Kun Chen; Chunmei Zhang; Chaojun Song; Liang Fang; Zhuwei Xu; Kun Yang; Boquan Jin; Qintao Wang; Lihua Chen
Journal:  Oncotarget       Date:  2016-04-12
View more
  4 in total

1.  [DNAM-1 regulates the proliferation and function of T regulatory type 1 cells via the IL-2/STAT5 pathway].

Authors:  N Wang; Y Wang; P Jiang; M Lü; Z Hu; X Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

Review 2.  Differential Role of PD-1 Expressed by Various Immune and Tumor Cells in the Tumor Immune Microenvironment: Expression, Function, Therapeutic Efficacy, and Resistance to Cancer Immunotherapy.

Authors:  Myeong Joon Kim; Sang-Jun Ha
Journal:  Front Cell Dev Biol       Date:  2021-11-22

Review 3.  TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy.

Authors:  Eugene Y Chiang; Ira Mellman
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 13.751

Review 4.  Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy.

Authors:  Daijun Wang; Yanmei Gu; Xin Yan; Chengdong Huo; Guan Wang; Yang Zhao; Muzhou Teng; Yumin Li
Journal:  Front Oncol       Date:  2022-03-30       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.